Area of research
Biomaterials · Oncology
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Cancer Immunotherapy and Biomarkers, COVID-19 Clinical Research Studies, and SARS-CoV-2 and COVID-19 Research.
Effects of the mitoxantrone thermosensitive liposome nanodelivery system on prostate cancer in vivo and in vitro
Case Report: Dialysis following sintilimab-induced stage 3 acute kidney injury: mechanism investigation and management strategies
Severe thyrotoxicosis induced by tislelizumab: a case report and literature review
Evaluation of New Folate Receptor-mediated Mitoxantrone TargetingLiposomes In Vitro
Toxic Epidermal Necrolysis Induced by Sintilimab: A Case Report
Fusion of Ssm6a with a protein scaffold retains selectivity on Na<sub>V</sub>1.7 and improves its therapeutic potential against chronic pain